105 related articles for article (PubMed ID: 15606028)
1. [Distribution of hydroxycamptothecin after aerosol inhalation in rabbits].
Chen J; Fang Y; Zhang HX; Huang LL; Qian XP; Liu BR
Yao Xue Xue Bao; 2004 Sep; 39(9):747-51. PubMed ID: 15606028
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tissue distribution, and the lactone/carboxylate equilibrium of hydroxycamptothecin delivered via aerosol in mice.
Hu W; Zhang C; Hu W; Fang Y; Hou W
Fitoterapia; 2012 Oct; 83(7):1291-8. PubMed ID: 22858157
[TBL] [Abstract][Full Text] [Related]
4. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tissue distribution study of 10-methoxycamptothecin in rats following intragastric administration.
Zheng J; Ji Y; Shao C; Jing L; Wang Y
J Pharm Biomed Anal; 2018 Feb; 149():564-571. PubMed ID: 29197298
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
8. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
Zhao YX; Liu DX; Liang WQ; Ye ZW
J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic study of intraperitoneal chemotherapy with HCPT].
Ye M; Lin XX; Pan HM; Li N; Lou F; Jin W; Zheng Y; Wu JM
Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(20):1610-2. PubMed ID: 16422545
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].
Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682
[TBL] [Abstract][Full Text] [Related]
11. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
[TBL] [Abstract][Full Text] [Related]
12. [Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles].
Zhang ZR; Lu W
Yao Xue Xue Bao; 1997; 32(3):222-7. PubMed ID: 11327027
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
Han M; Liu X; Guo Y; Wang Y; Wang X
Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
[TBL] [Abstract][Full Text] [Related]
14. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
[TBL] [Abstract][Full Text] [Related]
15. Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation.
Shi K; Tian Y; Jiang Y; Wang L; Cui F
Pharm Dev Technol; 2010 Dec; 15(6):644-52. PubMed ID: 19943738
[TBL] [Abstract][Full Text] [Related]
16. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism.
Xing H; Luo X; Li Y; Fan C; Liu N; Cui C; Li W
Pharm Biol; 2020 Dec; 58(1):152-156. PubMed ID: 31990625
[No Abstract] [Full Text] [Related]
17. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of hydroxycamptothecin nanosuspensions in rats.
Wang L; Hua HY; Liu WJ; Zhao YX; Zhang ZZ
Pharmazie; 2011 Jul; 66(7):547-8. PubMed ID: 21812333
[TBL] [Abstract][Full Text] [Related]
19. Enhanced nuclear delivery and cytotoxic activity of hydroxycamptothecin using o/w emulsions.
Zhao Y; Gao J; Sun X; Chen H; Wu L; Liang W
J Pharm Pharm Sci; 2007; 10(1):61-70. PubMed ID: 17498395
[TBL] [Abstract][Full Text] [Related]
20. Preparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymers.
Yang X; Li L; Wang Y; Tan Y
Int J Pharm; 2009 Mar; 370(1-2):210-5. PubMed ID: 19114094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
